...
首页> 外文期刊>Intensive and critical care nursing >Intermittent versus Continuous Renal Replacement Therapy: a matter of controversy.
【24h】

Intermittent versus Continuous Renal Replacement Therapy: a matter of controversy.

机译:间歇性与连续性肾脏替代治疗:一个有争议的问题。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Acute Renal Failure (ARF) requiring some form of replacement therapy is a frequent complication in the critically ill patient. Despite potential therapeutic advantages the expectation of an improvement in patient outcomes using Continuous Renal Replacement Therapy (CRRT) compared to conventional Intermittent Haemodialysis (IHD) remains controversial. AIMS AND METHOD: This article will review the literature on the issues surrounding the use of IHD versus CRRT in the management of the critically ill patient. Articles were selected according to level of evidence with priority given to meta-analyses and randomised controlled trials. DISCUSSION: Several operational features of CRRT allow this technique to be tolerated more easily in critical illness than IHD. The gradual removal of fluid reduces the incidence of hypotension and the risk of volume overload. Decreased variability in the concentration of solutes enables greater azotemia control. However, CRRT is required to operate uninterrupted toachieve a treatment dose that is equivalent to a conventional IHD treatment schedule. In the absence of definitive evidence to validate superior patient survival and return of renal function there is disagreement as to the most appropriate form of Renal Replacement Therapy (RRT) for the critically ill patient. The introduction of 'hybrid' therapies offers a further alternative treatment strategy, which combine favourable aspects of IHD and CRRT. CONCLUSION: The decision to use IHD or CRRT should be guided by the therapeutic needs of the patient rather than the operational differences between the two techniques. The resources and expertise available at the organisation are also important in determining the mode best able to manage the critically ill patient at any stage and may change according to the severity of illness. The emergence of hybrid therapies provides a compromise option which encompasses many of the features of both systems, but does not embrace all options of either approach.
机译:背景:在重症患者中,需要某种形式的替代疗法的急性肾衰竭(ARF)是常见的并发症。尽管具有潜在的治疗优势,但与常规的间歇性血液透析(IHD)相比,使用连续性肾脏替代疗法(CRRT)改善患者预后的期望仍然存在争议。目的和方法:本文将回顾有关重症患者管理中使用IHD与CRRT的相关问题的文献。根据证据水平选择文章,优先进行荟萃分析和随机对照试验。讨论:CRRT的几种操作功能使该技术在重症患者中比IHD更容易耐受。逐渐清除液体可降低低血压的发生率和容量超负荷的风险。降低溶质浓度的可变性可以更好地控制氮氧化物。但是,要求CRRT不间断运行以达到与常规IHD治疗方案相当的治疗剂量。在没有确切的证据来验证患者的优异生存率和肾功能恢复方面,对于重症患者最合适的肾脏替代疗法(RRT)形式存在分歧。 “混合”疗法的引入提供了进一步的替代治疗策略,该策略结合了IHD和CRRT的有利方面。结论:使用IHD或CRRT的决定应以患者的治疗需求为指导,而不是两种技术之间的操作差异。组织中可用的资源和专业知识对于确定最能在任何阶段管理重症患者的模式也很重要,并且可以根据疾病的严重程度而改变。混合疗法的出现提供了一个折衷的选择,它包含了两个系统的许多功能,但并不包含任何一种方法的所有选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号